NDC 68001-282-22 - Gemcitabine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68001-282
- Requested NDC
- 68001-282-22
- Package NDCs from labels
- 68001-282-22, 68001-282-25, 68001-282-23, 68001-282-26, 68001-282-24, 68001-282-27
- Manufacturer
- BluePoint Laboratories | Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2021-07-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gemcitabine Hydrochloride - BluePoint Laboratories | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | BluePoint Laboratories | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2021-07-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68001-282-22 | EA - Each | 68001-282 | aeb0c7ed-5d8a-4890-96a6-6d5d9953a6e7 | 1 | 2016-07-19 |
| 68001-282-23 | EA - Each | 68001-282 | 575b59c6-8897-475d-bfdc-f976c8da75aa | 1 | 2016-07-19 |
| 68001-282-24 | EA - Each | 68001-282 | 19e24296-3ad9-4869-b81b-042dddf1e9b8 | 1 | 2016-07-19 |
| 68001-282-25 | EA - Each | 68001-282 | 10a4f7e1-a20d-4fe1-ad2d-512744533ed4 | 1 | 2016-07-19 |
| 68001-282-26 | EA - Each | 68001-282 | 9d5e60fc-c391-43a6-b434-26e3a0e5ecb4 | 1 | 2016-07-19 |
| 68001-282-27 | EA - Each | 68001-282 | c193ed00-cacc-4fcf-ae22-4c7668199215 | 1 | 2016-07-19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Natrum Aceticum | NATRUM ACETICUM | Hahnemann Laboratories, INC. | 04cdea6c-8348-d855-e063-6294a90a6660 | 2023-09-07 | 4550K0SC9B | |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Multiple Electrolytes pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | 84221110-b3f1-42f4-800c-ad1d3b330e9e | 2022-11-10 | Warnings, Adverse reactions | 4550K0SC9B |
| Multiple Electrolytes pH 5.5 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | cf1f5f15-d31d-4a02-8f7e-b289d5ad4b5c | 2022-11-10 | Warnings, Adverse reactions | 4550K0SC9B |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | e4f06c0b-7cb1-49c9-97a4-2cfc21298495 | 2021-11-16 | Warnings, Adverse reactions | 4550K0SC9B |
| Solucion InterSol | SOLUCION ADITIVA PARA PLAQUETAS 3 | Fenwal, Inc. | d5eaf5f4-67d3-4475-af9a-f5b0f882f5d1 | 2021-10-04 | Warnings, Adverse reactions | 4550K0SC9B |
| c6640762-8bde-4b8a-e053-2a95a90a4673 | 23b02047-38ea-4dca-875f-3dbcc79e7fec | 2021-07-05 | Warnings, Adverse reactions | c6640762-8bde-4b8a-e053-2a95a90a4673 23b02047-38ea-4dca-875f-3dbcc79e7fec | ||
| CLINIMIX E | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE | Baxter Healthcare Company | 8469d6fb-d6ef-476f-8cc3-0905192de0a8 | 2021-04-13 | Warnings, Adverse reactions | 4550K0SC9B |
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | d1f3951c-d13f-4662-ad4b-ecfc07f59104 | 2021-01-20 | Warnings, Adverse reactions | U347PV74IL |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | 2020-10-20 | Warnings, Adverse reactions | 4550K0SC9B |
| Plasma-Lyte A | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Baxter Healthcare Corporation | 6ec9e61c-2c26-402f-8604-f446b2e34058 | 2019-08-05 | Warnings, Adverse reactions | 4550K0SC9B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.